Yellow Fever clinical trials

Explore recruiting yellow fever clinical trials.

Recruiting yellow fever studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Yellow Fever trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

YF_PROTECT: Prophylactic Treatment with Sofosbuvir for Yellow fever Exemption Circumstances and Travel

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal, subcutaneous and intramuscular yellow fever vaccination

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril® in Adults

Germany, Finland, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immunogenicity of AstriVax’ investigational vaccine for the prevention of yellow fever (AVX70120), and of AstriVax’ investigational vaccine for the prevention of rabies (AVX70481), in healthy adults aged 18 to 40 years.

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Low-Intervention Clinical Trial Evaluating a Novel Cytokine Release Assay for Tick-Borne Encephalitis (TBE) Among Healthy and Immunosuppressed Research Participants

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) – A phase 2 proof-of-concept, national, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy of remdesivir in adult patients hospitalized for TBE

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Yellow Fever trials by city

Yellow Fever in Toronto Yellow Fever in Vancouver Yellow Fever in Montreal Yellow Fever in Calgary Yellow Fever in Edmonton Yellow Fever in Ottawa Yellow Fever in Winnipeg Yellow Fever in Quebec City Yellow Fever in Hamilton Yellow Fever in Kitchener Yellow Fever in London Yellow Fever in Halifax Yellow Fever in New York Yellow Fever in Los Angeles Yellow Fever in Chicago Yellow Fever in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease